Koyfin Home > Directory > Health Care > Accuray Incorporated > EBITDA

Accuray Incorporated EBITDA Chart (ARAY)

Accuray Incorporated annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Accuray Incorporated EBITDA for the quarter ending June 06, 2020 was $7m a 133.60% increase of 10m year over year
  • Accuray Incorporated EBITDA for the last 12 months ending June 06, 2020 was $20m a 55.09% increase of 11m year over year
  • Accuray Incorporated Annual EBITDA for 2020 was $20m a 55.81% increase of 11m from 2019
  • Accuray Incorporated Annual EBITDA for 2019 was $9m a 33.12% increase of 3m from 2018
  • Accuray Incorporated Annual EBITDA for 2018 was $6m a -38.50% decrease of -2m from 2017
Other Income Statement Metrics:
  • Accuray Incorporated Net Income for the quarter ending December 12, 2018 was $-5m a -90.78% increase of 4m year over year
  • Accuray Incorporated Total Revenue for the quarter ending September 09, 2018 was $96m a -4.70% decrease of -5m year over year
View Chart On Koyfin

Quarterly ARAY EBITDA Data

06/2020$7m
03/2020$10m
12/2019$5m
09/2019$-2m
06/2019$5m
03/2019$5m
12/2018$1m
09/2018$-3m
06/2018$5m
03/2018$-1m

Annual ARAY EBITDA Data

2020$20m
2019$9m
2018$6m
2017$8m
2016$5m
2015$-8m
2014$2m
2013$-46m
2012$-24m
2011$-20m